Levy Howard 4
4 · CATALYST BIOSCIENCES, INC. · Filed Feb 4, 2019
Insider Transaction Report
Form 4
Levy Howard
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-01-31$4.63/sh+1,500$6,945→ 9,382 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-01-31−1,500→ 93,500 totalExercise: $4.63Exp: 2027-07-11→ Common Stock (1,500 underlying)
Footnotes (1)
- [F1]The Option vests monthly over a period of four years commencing June 15, 2017.